Treatment of Tuberculous Encephalopathy in Immunocompromised Patients

Diagnostic Approach

The American College of Physicians recommends obtaining a CT scan before lumbar puncture in patients with known severe immunocompromise to assess for mass effect or contraindications to LP 3, 4
The Infectious Diseases Society of America suggests performing MRI as soon as possible in all immunocompromised patients with suspected CNS tuberculosis 3, 4
The Centers for Disease Control and Prevention notes that CSF findings may be atypical in immunocompromised patients, who are more likely to have acellular CSF despite active infection, so CSF investigations for microbial pathogens should be performed regardless of cell count 4
Essential CSF testing for immunocompromised patients includes CSF acid-fast bacillus staining and culture for M. tuberculosis, CSF PCR for HSV 1 & 2, VZV, enteroviruses, EBV, and CMV, Indian ink staining and/or cryptococcal antigen testing, and CSF and blood culture for Listeria monocytogenes 3, 4

The World Health Organization recommends a four-drug anti-tuberculosis regimen (isoniazid, rifampin, pyrazinamide, and ethambutol) for 2 months, followed by isoniazid and rifampin for an additional 10 months (total 12 months) 1, 2
The American Thoracic Society states that the total treatment duration should be at least 12 months for CNS tuberculosis, which is longer than the 6 months used for pulmonary TB 5, 1, 2
Ethambutol should be used with caution in unconscious patients, as visual acuity cannot be tested, though the risk of ocular toxicity at 15 mg/kg is very small 5

The National Institutes of Health recommends dexamethasone dosing of 12 mg/day for 3 weeks, then tapering gradually over the following 3 weeks (total 6 weeks) for adults and children ≥25 kg 1, 2
For children <25 kg, the recommended dose is 8 mg/day for 3 weeks, then tapering over 3 weeks 6
Corticosteroids reduce mortality and neurological sequelae in tuberculous meningitis, with the greatest benefit seen in patients with altered consciousness 1, 2
The Infectious Diseases Society of America suggests that corticosteroids should be given to all patients regardless of disease severity 1, 2

The Centers for Disease Control and Prevention recommends using the same standard four-drug regimen for 12 months in HIV-infected patients 2
Highly intermittent regimens should be avoided in patients with CD4+ counts <100 cells/mm³ due to increased risk of rifampin resistance 2
Drug-resistant tuberculosis requires treatment with at least 3-5 drugs to which the organism is susceptible, and consideration of second-line agents such as fluoroquinolones, linezolid, bedaquiline, or aminoglycosides based on susceptibility testing 1, 2

The American Academy of Neurology recommends performing repeated lumbar punctures to monitor CSF cell count, glucose, and protein changes during early treatment 2
Monthly clinical assessment for signs of hepatitis (nausea, vomiting, abdominal pain, jaundice) is necessary, particularly during the first 2 months of treatment 7
Prompt neurosurgical referral is necessary for hydrocephalus or tuberculous cerebral abscess 1